BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 18568671)

  • 1. Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer.
    Smith RA; Tang J; Tudur-Smith C; Neoptolemos JP; Ghaneh P
    Br J Cancer; 2011 Apr; 104(9):1440-51. PubMed ID: 21448172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of apoptosis-related genes in female pelvic supportive tissues with regard to menopausal status.
    Saatli B; Kurt S; Çağlıyan E; Kızıldağ S
    Mol Biol Rep; 2023 Dec; 51(1):6. PubMed ID: 38085363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinguishing Low-Risk Luminal A Breast Cancer Subtypes with Ki-67 and p53 Is More Predictive of Long-Term Survival.
    Lee SK; Bae SY; Lee JH; Lee HC; Yi H; Kil WH; Lee JE; Kim SW; Nam SJ
    PLoS One; 2015; 10(8):e0124658. PubMed ID: 26241661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translational pathology of neoplasia.
    Grizzle WE; Srivastava S; Manne U
    Cancer Biomark; 2010; 9(1-6):7-20. PubMed ID: 22112467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of breast cancer subtype and p53 overexpression in patients with locally advanced or high-risk breast cancer treated using upfront modified radical mastectomy with or without post-mastectomy radiation therapy.
    Lee DS; Kim SH; Kim S; Suh YJ; Kim HK; Shim BY
    Int J Clin Oncol; 2012 Oct; 17(5):447-55. PubMed ID: 21898181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues.
    Yuan K; Frolova N; Xie Y; Wang D; Cook L; Kwon YJ; Steg AD; Serra R; Frost AR
    J Histochem Cytochem; 2010 Oct; 58(10):857-70. PubMed ID: 20530462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gli1 promotes cell survival and is predictive of a poor outcome in ERalpha-negative breast cancer.
    Xu L; Kwon YJ; Frolova N; Steg AD; Yuan K; Johnson MR; Grizzle WE; Desmond RA; Frost AR
    Breast Cancer Res Treat; 2010 Aug; 123(1):59-71. PubMed ID: 19902354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers.
    Frolova N; Edmonds MD; Bodenstine TM; Seitz R; Johnson MR; Feng R; Welch DR; Frost AR
    Tumour Biol; 2009; 30(3):148-59. PubMed ID: 19609101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of biomarkers in breast and prostate cancer.
    Grizzle WE; Myers RB; Arnold MM; Srivastava S
    J Cell Biochem Suppl; 1994; 19():259-66. PubMed ID: 7823598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for breast cancer.
    Beenken SW; Bland KI
    Minerva Chir; 2002 Aug; 57(4):437-48. PubMed ID: 12145573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women.
    Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR
    Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer.
    Ioachim E; Kamina S; Athanassiadou S; Agnantis NJ
    Anticancer Res; 1996; 16(5B):3141-7. PubMed ID: 8920782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer.
    Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.